Dow Up1.57% Nasdaq Up2.12%

Immune Pharmaceuticals, Inc. (IMNP)

-NasdaqCM
0.40 Up 0.02(5.31%) 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development2,011  2,531  1,127  1,127  
Selling General and Administrative2,413  3,578  2,227  1,681  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (4,424) (6,109) (3,354) (2,808)
Income from Continuing Operations
Total Other Income/Expenses Net(331)8  (608)(3)
Earnings Before Interest And Taxes(4,755)(6,101)(3,962)(2,811)
Interest Expense377  464  197  66  
Income Before Tax(5,132)(6,565)(4,159)(2,877)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(5,132)(6,565)(4,159)(2,877)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (5,132) (6,565) (4,159) (2,877)
Preferred Stock And Other Adjustments(886)(1,475)(3,669)(1,759)
Net Income Applicable To Common Shares (6,018) (8,040) (7,828) (4,636)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.